These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 31610723)

  • 1. Impaired Autophagy in CD11b
    Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
    Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of IRF8 (Interferon Regulatory Factor 8)-Dependent Dendritic Cells Abrogates Proatherogenic Adaptive Immunity.
    Clément M; Haddad Y; Raffort J; Lareyre F; Newland SA; Master L; Harrison J; Ozsvar-Kozma M; Bruneval P; Binder CJ; Taleb S; Mallat Z
    Circ Res; 2018 Mar; 122(6):813-820. PubMed ID: 29436389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
    Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC
    Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
    Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell subset distributions in the aorta in healthy and atherosclerotic mice.
    Busch M; Westhofen TC; Koch M; Lutz MB; Zernecke A
    PLoS One; 2014; 9(2):e88452. PubMed ID: 24551105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
    Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice.
    Macritchie N; Grassia G; Sabir SR; Maddaluno M; Welsh P; Sattar N; Ialenti A; Kurowska-Stolarska M; McInnes IB; Brewer JM; Garside P; Maffia P
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2569-79. PubMed ID: 22936340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Foks AC; Engelbertsen D; Kuperwaser F; Alberts-Grill N; Gonen A; Witztum JL; Lederer J; Jarolim P; DeKruyff RH; Freeman GJ; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):456-65. PubMed ID: 26821944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
    Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.
    Subramanian M; Thorp E; Hansson GK; Tabas I
    J Clin Invest; 2013 Jan; 123(1):179-88. PubMed ID: 23257360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression.
    Bonacina F; Martini E; Svecla M; Nour J; Cremonesi M; Beretta G; Moregola A; Pellegatta F; Zampoleri V; Catapano AL; Kallikourdis M; Norata GD
    Cardiovasc Res; 2021 Jul; 117(9):2069-2082. PubMed ID: 32931583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenteric lymph node CD11b
    Shiokawa A; Kotaki R; Takano T; Nakajima-Adachi H; Hachimura S
    Immunology; 2017 Sep; 152(1):52-64. PubMed ID: 28423181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
    Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
    Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Schäfer S; Gogiraju R; Rösch M; Kerstan Y; Beck L; Garbisch J; Saliba AE; Gisterå A; Hermanns HM; Boon L; Kastenmüller W; Schäfer K; Cochain C; Zernecke A
    Arterioscler Thromb Vasc Biol; 2024 Aug; 44(8):1852-1872. PubMed ID: 38868941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
    Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G
    Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.